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To evaluate the utility of tetracycline gene regulation in the study of human cytomegalovirus gene functions, expression of
luciferase under the control of tetracycline-regulatable promoters was studied following transient plasmid transfections and
from within recombinant human cytomegalovirus genomes. The tetracycline-regulatable promoter PhCMV*-1 contains se-
quences from the human cytomegalovirus ie1/ie2 promoter and seven upstream tet operator sites which bind the activator
protein tTA only in the absence of tetracycline (Gossen and Bujard (1992). Proc. Natl. Acad. Sci. USA 89, 5547–5551). Two
modifications of PhCMV*-1 were also studied: P1129, in which the tet operator sites were reduced from seven to one; and P1125,
in which human cytomegalovirus sequences were replaced by adenovirus major late promoter and terminal deoxynucleoti-
dyltransferase initiator sequences. In transient assays, PhCMV*-1 and P1125 exhibited modest differential regulation but were
strongly activated by viral infection. P1129 exhibited less viral activation and narrower regulation. In the viral genome, PhCMV*-1
exhibited regulation up to 7-fold during late times of infection, whereas P1125 displayed nearly 100-fold regulation. Regulation
of P1125 was fully reversed within 12 to 24 h of adding or removing tetracycline. These results suggest that P1125 may provide
sufficient conditional expression to effectively regulate human cytomegalovirus late genes. © 1999 Academic Press
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The human cytomegalovirus (HCMV) genome is the
argest of the characterized mammalian viruses and has
otential to encode over 200 genes (Chee et al., 1990).
he majority of these genes remain uncharacterized, in
art because the construction of constitutive or condi-
ional mutations in HCMV has been difficult owing to its
arge genome size, slow growth rate, and restriction for
fficient growth in vitro to limited life span primary hu-
an fibroblast (HF) cells. In recent years, however, ret-
oviral vectors have been developed that can signifi-
antly extend the life span of HF cells by transduction of
he human papillomavirus type 16 E6 and E7 genes
Compton, 1993; Halbert et al., 1991). This has allowed
he construction of complementing HF cell lines that
xpress individual HCMV genes (Mocarski et al., 1996) or
ther proteins that may be useful in evaluating viral gene
unctions in the context of productive viral infection.
Exogenous regulation of viral gene expression may
rovide an effective means to characterize genes in
CMV or other large DNA viruses. Regulatory mecha-
isms based on the ability of the antibiotic tetracycline
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Pediatrics, Medical College of Virginia Cam-
us of Virginia Commonwealth University, P.O. Box 980163 MCV Station,
ichmond VA 23298-0163. Fax: (804) 828-6455. E-mail: mmcvoy@csc.vcu.edu.
295Tc) to control the DNA binding properties of chimeric
epressor or activator proteins have been used to effec-
ively regulate expression of heterologous genes intro-
uced into mammalian cells either by transfection (Deus-
hle et al., 1995; Gossen et al., 1993; Gossen and Bujard,
992) or by a variety of viral gene therapy vectors, includ-
ng defective retroviruses (Hofmann et al., 1996; Hwang
t al., 1996; Iida et al., 1996; Kim et al., 1997; Lindemann
t al., 1997; Paulus et al., 1996; Watsuji et al., 1997; Yu et
l., 1996), herpes simplex virus amplicon vectors (Fotaki
t al., 1997; Ho et al., 1996), adenoviruses (Harding et al.,
997; Neering et al., 1996; Yoshida and Hamada, 1997),
nd adeno-associated viruses (Bertran et al., 1996) (re-
iewed in (Saez et al., 1997; Shockett and Schatz, 1996)).
c-regulatable promoters have also been applied to the
tudy of viral genes. For example, repression of a Tc-
egulatable promoter inserted into the adenovirus ge-
ome upstream of the gene for the viral DNA binding
rotein reduced the steady-state levels of the DNA bind-
ng protein by 90% and significantly impaired viral DNA
ynthesis (Rittner et al., 1997). For viruses with a pro-
onged course of replication such as HCMV (72 to 96 h),
t may also be possible to activate or repress viral genes
t various times during the replication cycle.
We have adapted the Tc-regulatable promoter system
eveloped by Gossen and Bujard (Gossen et al., 1993;
ossen and Bujard, 1992), which consists of two com-
onents: (1) a promoter, PhCMV*-1, which contains seven
opies of the Escherichia coli tet operator (tetO) up-
0042-6822/99 $30.00
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296 MCVOY AND MOCARSKItream of sequences from the HCMV ie1/ie2 promoter
253 to 175, relative to the transcriptional start site) (see
ig. 1A); and (2) a chimeric transactivator protein (tTA)
hat consists of the transactivation domain of herpes
implex virus type 1 VP16 fused to the DNA binding
omain of the Tc repressor (Gossen et al., 1993; Gossen
nd Bujard, 1992). In the absence of Tc, tTA binds to the
etO sites of PhCMV*-1 and activates expression, whereas in
he presence of Tc, tTA is released from tetO sites and
ene expression is reduced. To determine the suitability
f this system for regulation of genes in HCMV, we
reated an HF cell line that expressed tTA. Transient
ntroduction of plasmids into these cells was used
o compare regulation of luciferase expression from
hCMV*-1 and modifications of PhCMV*-1 in the presence or the
bsence of HCMV infection. PhCMV*-1 and one of the mod-
fied promoters, P1125, were then compared in the context
f the HCMV genome by construction of recombinant
iruses. P1125 was expressed and effectively regulated
rom within the HCMV genome at late times of infection.
RESULTS
F cells expressing tTA
HFs expressing the tTA chimeric activator were de-
ived following unlinked cotransfection of the plasmids
BABEpuro (Morgenstern and Land, 1990) and
UHD15-1 (Gossen and Bujard, 1992). Cell lines which
rew under puromycin selection were tested for Tc reg-
lation of luciferase expression from transiently trans-
ected pUHC13-3 DNA, which contains luc expressed
FIG. 1. Structure of promoter constructs and levels of Tc regulation
ade by Gossen and Bujard (Gossen et al., 1993; Gossen and Bujard,
ate promoter and TdT initiator (adeno/Td) replace the HCMV ie1/ie2 p
eplaced by a single tetO site, which is adjacent to the same HCMV
onstruction of P1125 and P1129 are shown in A. Structures and key featur
esults from transfecting HFT-3 cells with each plasmid construct are
resence or the absence of 1 mg/ml of Tc and either mock infected of
ere lysed and assayed for luciferase activity.rom PhCMV*-1 (Gossen and Bujard, 1992). Duplicate wells Hf each cell line were DEAE dextran transfected with
UHC13-3 and incubated with culture medium with or
ithout Tc (1 mg/ml). Forty-eight hours after transfection
he cells were assayed for luciferase activity. One cell
ine exhibited a 20-fold decrease in luciferase activity in
he presence of Tc (data not shown) and this line was
ubsequently infected with a amphotropic retrovirus con-
aining the human papillomavirus type 16 E6 and E7
enes to extend its life span (Compton, 1993; Greaves et
l., 1995). The resulting line was designated HFT-3.
ransient expression in HCMV-infected cells
To determine the impact of HCMV infection on
hCMV*-1 expression, pUHC13-3 DNA was transiently trans-
ected into HFT-3 cells as described above and replicate
ultures were mock treated or infected with HCMV strain
D169 at an M.O.I. of 10. HCMV infection consistently
nduced dramatic increases in the levels of luciferase
xpression in both the presence and the absence of Tc.
representative experiment is shown in Fig. 1A, in which
CMV infection increased expression approximately
00-fold. In other experiments, activation by HCMV
anged from 50- to 370-fold and this level of activation
as also observed in parental HFs, independent of the
TA transactivator (not shown). Despite this strong acti-
ation by virus infection, luciferase activity was still re-
ponsive to Tc treatment. In the experiment shown, 1
g/ml Tc resulted in a 3-fold (Fig. 1A) decrease in ex-
ression 24 h postinfection (hpi), but in other experi-
ents this ranged up to 15-fold (not shown).
In an effort to remove DNA sequences responsive to
rase expression from transfected plasmids. (A) The PhCMV*-1 construct
(B) The P1125 construct in which sequences from the adenovirus major
r in PhCMV*-1. (C) The P1129 construct in which the seven tetO sites are
promoter sequences found in PhCMV*-1. The restriction sites used for
ach promoter are illustrated on the left and bar graphs illustrating the
to the right of each panel. Transfected cells were incubated in the
with HCMV 24 h after transfection. After an additional 24 h, the cellsof lucife
1992).
romote
ie1/ie2
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shown
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297TETRACYCLINE GENE REGULATION IN HCMVess, several derivatives of PhCMV*-1 were constructed and
ested by transient transfection into HFT-3 cells. Figure 1
llustrates the structures of PhCMV*-1 and two modifications,
esignated P1125 and P1129, that were selected for further
tudy. In PhCMV*-1, seven tetO elements lie upstream of
CMV ie1/ie2 promoter sequences (253 to 175, relative
o the HCMV ie1/ie2 transcriptional start site (Gossen
nd Bujard, 1992)) and include the ie1/ie2 TAATA ele-
ent, negative regulatory crs element (Cherrington et al.,
991), and SP1 binding site (Lang et al., 1992). In P1125, the
even tetO elements were retained as in PhCMV*-1, but all
CMV promoter sequences were replaced with a 23-bp
AATA containing element from the adenovirus major
ate promoter fused to a 17-bp initiator from the mouse
dT gene (Shi et al., 1991; Smale and Baltimore, 1989). In
1129, the PhCMV*-1 HCMV ie1/ie2 promoter sequences were
etained but the seven 45-bp tetO elements were re-
laced by a single copy of a 21-bp minimal tetO element
Sizemore et al., 1990).
In uninfected cells, the absence of Tc induced small
ncreases (,3-fold) in expression from all three promot-
rs, while virus infection resulted in strong transactiva-
ion that was only partially reversed by addition of Tc (Fig.
). In the presence of Tc and viral infection, expression
rom P1129 was only slightly lower than that from PhCMV*-1 or
1125, suggesting that a only a small amount of transac-
ivation occurred via the adjacent multiple tetO sites in
hCMV*-1 or P1125, and the majority occurred via the HCMV
r adenovirus promoter elements. Interestingly, in the
resence of viral infection, the absence of Tc increased
1125 expression 12-fold, whereas expression from P1129
ncreased 7-fold and PhCMV*-1 increased 3-fold. In a repli-
ate experiment (not shown), expression from P1125 in-
reased 17-fold, while expression from PhCMV*-1 and P1129
ncreased 14- and 1.5-fold, respectively. These results
ndicated that the combination of adenovirus promoter,
dT initiator, and seven upstream tetO binding sites
rovided a higher degree of Tc regulation in the pres-
nce of HCMV transactivation.
romoter regulation of luciferase within recombinant
iruses
Transient assays only provide a rough indication of the
evels of regulation of a promoter placed in the context of
he viral genome. To study regulation in a more physio-
ogical setting, we introduced the PhCMV*-1-luc and P1125-luc
onstructs into the HCMV US2-US6 region to create
ecombinant viruses RC2625 and RC2626 (Fig. 2A). The
nsertions were identical except for the presence of dif-
erent promoters and in each case resulted in complete
eletion of the US3, US4, and US5 ORFs and portions of
he US2 and US6 ORFs. To confirm the predicted struc-
ures of these viruses, DNA prepared from extracellular
irions of each virus was digested with SacI, separated
y agarose gel electrophoresis, transferred to a nylon aembrane, and hybridized with 32P-labeled pON2626, a
robe detecting the gpt-luc insertion as well as flanking
CMV sequences (Fig. 2A). The probe hybridized to a
redicted 4.8-kb SacI fragment in DNA from the parental
CMV strain Towne virus which was replaced by 1.9-
nd 4.4-kb SacI fragments in DNAs from the two recom-
inant viruses (Fig. 2B). These fragments are consistent
ith the presence of the predicted insertions in RC2625
nd RC2626 (Fig. 2A). Within the limits of detection by
ybridization, the absence of 4.8-kb SacI fragments indi-
ated that recombinant virus stocks did not contain any
ild-type virus. The promoters in RC2625 and RC2626
ontain additional, closely spaced (50–100 bp) SacI sites
Fig. 2A) that were not resolved by this analysis.
Replicate cultures of HFT-3 cells were infected at an
.O.I. of 5 with each of these viruses in the presence or
he absence of 1 mg/ml Tc. Triplicate cultures were lysed
t 1, 24, 48, 72, and 96 hpi and assayed for luciferase
ctivity. To assure comparable results, frozen cell-free
tocks of these viruses were titrated three times, with
dentical results, prior to use. RC2625 exhibited maxi-
um activated to repressed ratios of 7:1 and was only
ifferentially regulated at the latest time point (Fig. 2C).
C2626 exhibited greater regulation by Tc, with a differ-
nce first noted at 48 hpi and a maximum activated to
epressed ratio of 40:1 at 96 hpi (Fig. 2C). In experiments
ot shown, ratios for RC2626 ranged from 30:1 to 60:1,
hereas in the experiment shown in Fig. 3 a ratio of 98:1
as observed. Very similar results were observed when
nfections were carried out at an M.O.I. of 0.5 (data not
hown). These experiments indicated that P1125 had im-
roved Tc regulation characteristics for use in the viral
enome.
inetics of regulation of P1125 in RC2626
We employed RC2626 to further characterize the kinet-
cs of regulation and gene expression from P1125. To
ssess regulation across a range of Tc concentrations,
riplicate cultures of HFT-3 cells were infected with
C2626 at an M.O.I. of 5 in the presence of 10-fold
ncreases in Tc concentration, ranging from 0 to 10 mg/
l. All cultures were lysed at 96 hpi and assayed for
uciferase activity. No repression of luciferase expres-
ion was observed with 1 ng/ml Tc, intermediate levels of
epression were observed with 10 ng/ml, and maximal
epression was attained with concentrations as low as
00 ng/ml (data not shown).
To determine the time required to activate or repress
xpression when Tc was removed from or added to
nfected cell cultures, HFT-3 cells were infected with
C2626 at an M.O.I. of 5. One group of cultures was
reated with 0.2 mg/ml Tc, while a second group was not
reated with Tc at any time. In this experiment, the max-
mum activated to repressed ratio of expression was 98:1
t 96 hpi (Fig. 3). Results from these cultures were
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298 MCVOY AND MOCARSKIompared to cultures in which Tc was either removed or
dded at 24, 48, or 72 hpi. At 24- and 48-h time points, the
esponse to Tc was essentially complete within 12 h. For
xample, within 12 h of adding Tc at 48 h, luciferase
ctivity decreased to a level similar to that from cultures
hich contained Tc from the start of infection (Fig. 3A).
imilarly, within 12 h of removing Tc at 48 h, luciferase
ctivity increased to a level equivalent to that from cul-
ures which were never treated (Fig. 3B). The response
ime was longer when Tc was added or removed at 72
pi, with intermediate levels reached at 12 h and a
omplete response attained 24 h after either removal or
ddition of Tc (Fig. 3). Higher concentrations of Tc were
ested (10 mg/ml) but proved to be difficult to reverse
data not shown), perhaps because intracellular Tc was
arder to remove under these conditions.
Finally, the kinetic class of the P1125 in RC2626 was
nvestigated. To determine whether the P1125 promoter
FIG. 2. Genome structure and Tc regulation of recombinant viruses co
train Towne genome (top line) with a 4.8-kb SacI fragment from the U
etween the NheI and StuI sites within this SacI fragment were replaced
nd differs only by the respective Tc-regulatable promoter, PhCMV*-1 or P
sed as a hybridization probe in B. (B) Autoradiograph of DNA blot hy
NAs from the indicated viruses were digested with SacI, separated by
ith 32P-labeled pON2626 DNA. (C) HFT-3 cells were infected at an M
resence or the absence of 1 mg/ml Tc. The cells were lysed at the tixhibited a, or immediate early gene expression, HFT-3 pells were infected with RC2626 (M.O.I. of 5) and treated
ith 50 mg/ml cycloheximide from 0 to 12 hpi, then
ashed to remove the cycloheximide, and cultured with
edium containing 5 mg/ml actinomycin D. Little evi-
ence of luciferase activity was observed following re-
oval of the cycloheximide in either Tc-treated or un-
reated cultures, suggesting that P1125 was not expressed
s an a gene (data not shown).
To determine if the P1125 promoter exhibited b (early) or
(late) gene expression, HFT-3 cells were infected with
C2626 at an M.O.I. of 5 in the presence or the absence
f 1 mg/ml Tc and either mock treated or treated with 200
g/ml phosphonoformic acid (PFA) to block viral DNA
ynthesis. Although Tc regulated expression five- to six-
old in the presence of PFA, expression levels were
educed relative to the no drug control at 48, 72, and 96
pi, indicating that a significant amount of expression
as dependent on DNA synthesis (Fig. 4). Even in the
g gpt-luc expression cassettes. (A) HindIII restriction map of the HCMV
shown expanded below. In viruses RC2625 and RC2626, sequences
pt-luc expression cassettes, each of which is shown diagrammatically
low, a thick line indicates sequences contained in plasmid pON2626,
ion to detect sequences in the region of the gpt-luc insertions. Virion
e gel electrophoresis, transferred to a nylon membrane, and hybridized
5 with recombinant viruses RC2625 or RC2626 and incubated in the
icated and the lysates were assayed for luciferase activity.ntainin
S region
with g
1125. Be
bridizat
agaros
.O.I. ofresence of PFA, however, expression reached levels
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299TETRACYCLINE GENE REGULATION IN HCMVhat were 100-fold greater than background, suggesting
hat P1125 has characteristics of a b2 or a g1 gene in the
ontext of the viral genome (Mocarski, 1996).
DISCUSSION
The use of regulatable promoters to study viral gene
unction presents several potential advantages over con-
truction of knockout mutations. Expression of viral
enes could be activated or inactivated during replica-
ion to determine whether expression is required only at
pecific stages of replication, if inappropriate expression
s detrimental to viral replication, or if expression follow-
ng prolonged repression results in reversal of the phe-
FIG. 3. Kinetics of P1125 induction and repression. HFT-3 cells were i
hroughout the experiment with 0.2 mg/ml Tc were compared to culture
A) or removed from treated cultures by three washes (B) 24, 48, or 72
or luciferase activity.
FIG. 4. Expression and regulation of P1125 under early conditions.
egulation of early expression in the presence of 200 mg/ml phospho-
oformic acid (PFA) was compared to late gene expression (no drug).
FT-3 cells were infected with RC2626 at an M.O.I. of 5 in the absence
r the presence of 1 mg/ml Tc. The cells were lysed at the timeswndicated and assayed for luciferase activity.otype. More practical advantages include the potential
o modulate expression to more accurately mimic natural
nfection, which might result in higher titer viral stocks,
nd the ability to construct and characterize mutations
ffecting different genes using a single cell line, thereby
bviating difficulties inherent to cell line construction.
In our initial investigations of regulatable promoters to
ontrol HCMV gene expression, reporter plasmids were
ransiently introduced into stable HF cells expressing
TA. The 20-fold range of Tc regulation that we observed,
lthough considerably less than the 105-fold range re-
orted for PhCMV*-1-luc constructs in stably transfected
eLa cells (Gossen et al., 1993; Gossen and Bujard,
992), is comparable to ranges of regulation reported for
number of other cell types (Ackland-Berglund and Leib,
995; Hofmann et al., 1996; Paulus et al., 1996). Infection
f plasmid-transfected cells with HCMV, however, ele-
ated luciferase expression several hundred fold with-
ut significantly altering Tc regulation. Modifications in
hCMV*-1 were tested in plasmid transfection experiments
ith the goal of removing sequences responsible for
CMV activation without affecting Tc regulation. Reduc-
ion of the number of tetO sites from seven to one in P1129
lightly attenuated HCMV activation in plasmid transfec-
ions but reduced the range of Tc regulation. In P1125, the
CMV ie1/ie2 promoter element was replaced by ade-
ovirus promoter and terminal deoxynucleotidyltrans-
erase (TdT) initiator sequences. This had little effect on
he degree of HCMV activation but broadened the range
f Tc regulation both in plasmid transfections and in the
ontext of the viral genome.
In the context of the viral genome, P1125 achieved
anges of regulation as high as 98-fold, whereas PhCMV*-1
with RC2626 at an M.O.I. of 5. Untreated cultures or cultures treated
ich medium containing 0.2 mg/ml Tc was added to untreated cultures
ected cells were lysed at the times indicated and the lysates assayednfected
s in wh
hpi. Infas poorly regulated, achieving 7-fold regulation at best.
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300 MCVOY AND MOCARSKIegulation of P1125 was observed over the latter part of
he HCMV replication cycle and at either a high or a low
.O.I. infection. The highest expression and widest
ange of regulation occurred at late times (72–96 hpi),
ith lower levels of expression and regulation observed
hen viral DNA replication was inhibited. Therefore, P1125
s suitable for regulation of HCMV genes expressed at
ate times of infection. The 12- to 24-h response time for
c repression or activation should enable experiments to
etermine the effects of delayed gene expression or
ene inactivation after initial expression.
Induction of reporter genes within the HCMV genome
as been achieved using other systems. Takekoshi et al.
1993) used the mouse metallothionein promoter to con-
rol lacZ within the HCMV genome and found that inclu-
ion of Zn in the culture medium increased b-galactosi-
ase expression 27-fold 3 days after infection (Takekoshi
t al., 1993). Although this system does not require spe-
ial transgenic cells, the pliotrophic and perhaps toxic
ffects of Zn pose a significant concern, whereas Tc at
he doses used here does not have known adverse
ffects on mammalian cells. The Tc regulation system of
im et al. (1995) used tTA as a repressor to block ex-
ression from the HCMV US11 promoter, to which they
ad added several tetO sites both 59 and 39 of the TAATA
lement. When tTA-expressing U373-MG astrocytoma
ells were infected with a recombinant HCMV containing
he b-glucuronidase gene under control of this promoter,
inding of tTA to the promoter prevented expression. In
he presence of Tc, tTA no longer bound the promoter
nd expression of b-glucuronidase increased up to 120-
old at 20 hpi (Kim et al., 1995). Thus, at least at early
imes in the replication cycle, this promoter may be
uperior to P1125, which was not regulated at 24 hpi;
owever, it is not known how the promoter created by
im et al. performs at latter stages of viral replication or
n HFs, which are more efficient at supporting HCMV
ransactivation and replication.
Although these studies and the one reported here
ave demonstrated respectable ranges of regulation us-
ng reporter genes, to be useful in the study of viral gene
unction, a regulatable promoter must be capable of near
ormal levels of expression (vis-a`-vis the viral gene of
nterest) and significant repression below that level. How
evels of expression from any of these regulatable pro-
oters compare to expression from endogenous viral
romoters needs to be established. Future experiments
ill endeavor to utilize P1125 to regulate viral genes.
MATERIALS AND METHODS
ells and virus culture
HFs were isolated and propagated as previously de-
cribed (Greaves et al., 1995) using Dulbecco’s modified
ssential medium (DMEM) supplemented with 10%
uSerum or fetal bovine serum (culture medium). HCMV Xtrains AD169, Towne, and recombinant viruses were
ropagated using HF cells as previously described
Greaves et al., 1995). Recombinant virus stocks were
itered by infectivity endpoint assays on HFs in 96-well
lates following infection with 100 ml/well of 10-fold se-
ially diluted stocks. Unless otherwise noted, chemicals
ere obtained from Sigma. Stocks of puromycin (5 mg/
l), phosphonoformic acid (100 mg/ml), and cyclohexi-
ide (50 mg/ml) were prepared in water and sterilized by
iltration through 0.2-mm syringe filters. Stocks of Tc (10
g/ml) and actinomycin D (2 mg/ml) were dissolved in
00% ethanol.
lasmid construction
Plasmids pUHC13-3 and pUHD15-1 were gifts of H.
ujard (Gossen and Bujard, 1992); plasmid pTI was a gift
rom Dirk Dittmer (Shi et al., 1991); and plasmid pBABE-
uro was a gift from Cynthia Bolovan (Morgenstern and
and, 1990). Plasmid pON2530 contains 4.7 kb of HCMV
equences between nucleotides 192648 and 197398 in
he HCMV genomic sequence (Chee et al., 1990) and a
.2-kb deletion that removes nucleotides 194115 through
95326 (Greaves et al., 1995). pON1120 was constructed
y ligation of an XhoI–BsaI fragment from pON1101
Vieira et al., 1994), containing gpt and part of b-lacta-
ase, to an XhoI–BsaI fragment from pUHC13-3, which
ontained the luc cassette and the remainder of b-lac-
amase. Key promoter elements and restriction enzyme
ites used to create modifications to the original ar-
angement of tetO and promoter elements in pUHC13-3
re shown in Fig. 1. Plasmid pON1122 was made by
igestion of pUHC13-3 with KpnI, followed by ligation to
elete all HCMV sequences from the promoter. Plasmid
ON1125 was constructed by ligation of a 77-bp BglII–
amHI fragment from pTI into BamHI-digested pON1122.
his 77-bp fragment (AGATCGATATCATCGATGAATT-
GGGCTATAAAAGGGGGTGGGGGGAGCTCGGCCCT-
ATTCTGGAGACGGATCC) contains 23 bp from the ad-
novirus major late promoter (underlined) fused to a
7-bp initiator from the mouse TdT gene (bold) (Shi et al.,
991; Smale and Baltimore, 1989). To make plasmid
ON1121, multiple cloning site sequences were removed
rom pUHC13-3 by digestion with BamHI and SacII and
he ends were made blunt using T4 DNA polymerase and
NTPs (Tabor et al., 1994) prior to ligation. In plasmid
ON1124, the seven tetO sites were removed from
ON1121 by digestion with XhoI and SmaI and the ends
ere made blunt with Klenow polymerase and dNTPs
Tabor et al., 1994) prior to ligation. In plasmid pON1129,
ne copy of a single, minimal tetO site (Sizemore et al.,
990) was introduced upstream of the HCMV ie1/ie2
romoter sequences by annealing of oligonucleotides
ET-1 (59-TCGAGACTCTATCATTGATAGAGTG) and TET-2
59-TCGACACTCTATCAATGATAGAGTC) and ligation to
hoI-digested pON1124 DNA. In plasmid pON1133, the
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301TETRACYCLINE GENE REGULATION IN HCMVpstream XhoI site of pON1125 was converted to a BglII
ite by ligation of a self-annealed BglII linker (59-GAA-
ATCTTC) to pON1125 DNA that had been XhoI digested
nd blunt-ended with Klenow and dNTPs (Tabor et al.,
994).
To make pON2625, the gpt/luc region from pON1120
as inserted into HCMV sequences in pON2530 by liga-
ion of a 4.4-kb EaeI–SpeI fragment from pON1120 to
heI–StuI-digested pON2530 DNA. This deleted an ad-
itional 1.3 kb of HCMV sequences such that the gpt/luc
assette was flanked on one side by HCMV sequences
rom 192648 to 193364 and on the other side by HCMV
equences 195706 to 197398. To make plasmid
ON2626, a BglII–PacI fragment in pON2625 was re-
laced by an analogous BglII–PacI fragment from
ON1133.
onstruction of tTA-expressing HF cells
Plasmid pUHD15-1 (30 mg) was linearized by BsaI
igestion and 7.5 mg of plasmid pBABEpuro was linear-
zed by EcoRI digestion. Plasmid DNAs were extracted
nce with phenol/chloroform and once with chloroform,
thanol precipitated, and resuspended in 20 ml of 10 mM
ris, 1 mM EDTA, pH 8.0 (TE buffer). Passage six primary
F cells (106) were plated into one 175-cm2 tissue culture
lask 24 h prior to electroporation. Just prior to electro-
oration, cells were removed from the monolayer by
rypsinization, pelleted by centrifugation for 5 min at
00g, resuspended in 0.45 ml of Opti-MEM (BRL), mixed
ith the linearized pUHD15-1 and pBABEpuro plasmid
NA, transferred to a 0.4-cm electroporation cuvette
Bio-Rad), and chilled on ice. Electroporation was carried
ut with a capacitance of 960 mF at 220 V. After 10 min on
ce, electroporated cells were diluted into 24 ml of me-
ium and plated 1 ml/well into a 24-well plate. After the
ells were allowed to attach overnight, the medium was
eplaced with medium containing 0.5 mg/ml puromycin
Sigma), which was changed daily for 1 week and every
ther day for a second week. Puromycin-resistant HFs
ere immortalized as previously described (Compton,
993; Greaves et al., 1995) by infection with the ampho-
ropic retrovirus LXSN16E6E7 (Halbert et al., 1991).
EAE dextran transfection
HFT-3 cells were split 1:3 into 24-well plates 24 h prior
o transfection. For each well, 0.3 g of plasmid DNA was
ixed with 200 ml serum-free DMEM containing 50 mM
ris (pH 7.6) and DEAE dextran (Sigma) to a final con-
entration of 200 mg/ml. The culture medium was then
emoved from the wells and the cells were overlaid with
80 ml of this mixture and incubated at 37°C. After 4 h, 1
l DMEM containing 10% NuSerum and 5% dimethyl
ulfoxide (Sigma) was added to each well. After 2 min at
oom temperature, cells were washed once with culture wedium and incubated at 37°C following the addition of
ml of medium per well.
uciferase assay
Luciferase activity was detected with a luciferase kit
ccording to the manufacturer’s instructions (Promega).
ell lysates were prepared by washing the cells of each
ell in a 24-well plate (2 cm2) twice with PBS, adding 50
l of Promega lysis butter, and rotating gently for 15 min
t room temperature. The resulting lysates were then
larified by centrifugation for 5 s at 13,000g and the
upernatants stored at 270°C until assay. Luciferase
ctivity was measured by mixing 5 ml of supernatant with
5 ml Promega substrate solution and immediately as-
aying light emission using a Hewlett–Packard scintilla-
ion counter set for single photon counting and full wave-
ength detection.
ecombinant virus construction
Viruses were constructed following a plasmid trans-
ection and viral infection protocol that employed gpt
election as described by Greaves et al. (1995). Plasmids
ON2625 and pON2626 were used to construct RC2625
nd RC2626, respectively. For each electroporation, cells
nd plasmid DNAs were prepared as described for con-
truction of tTA-expressing HF cells except that 30 mg of
arental plasmid DNA was digested with BsaI, which
uts these plasmids once at HCMV genomic nucleotide
osition 192861, 503 bp from the gpt/luc cassette. Elec-
roporation was performed using an Electroporator II
pparatus (Invitrogen) set to 300 V, 1000 mF, and infinite
esistance. Cells were kept on ice in the cuvette for 10
in after electroporation, then diluted into 10 ml of cul-
ure medium, and placed in a 25-cm2 flask overnight.
ttached cells were then infected with HCMV strain
owne at a M.O.I. of 5. Three hours later the cells were
ashed three times with culture medium and incubated
or 5 days under 5 ml of culture medium. After clarifica-
ion by low-speed centrifugation (800g for 5 min), all 5 ml
f culture supernatant was used to infect a fresh 25-cm2
lask of confluent HFs. Three hours after infection, the
ells were washed once with medium and incubated
ith 5 ml of medium containing 100 mM mycophenolic
cid (BRL) and 25 mM xanthine (Sigma). The culture
upernatant was collected 5 days later, clarified by cen-
rifugation, and used to infect fresh HF cells under the
ame conditions. This process was repeated one more
ime to select for gpt1 viruses. Viral cytopathic effects
ere usually evident 7 to 14 days after the third round of
election and virus clones were isolated by plating serial
0-fold dilutions of clarified culture supernatants into
6-well plates containing HFs. After 14 to 21 days, virus
n culture supernatants from wells of plates with the
ewest virus-positive wells were removed and storedhile the cells were lysed and assayed for luciferase
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302 MCVOY AND MOCARSKIxpression as described above, except that cells from
ne well of a 96-well plate were lysed with 16 ml lysis
uffer. Viruses from luciferase-positive wells were
loned as describe above by limiting dilution in 96-well
lates and virus clones were again assayed for lucif-
rase expression. Candidate virus genome structure
as confirmed by DNA-blot hybridization.
NA blot hybridization
DNAs were prepared from extracellular virions essen-
ially as previously described for guinea pig cytomega-
ovirus (McVoy et al., 1997), restriction enzyme digested,
lectrophoresed on 0.6% agarose, transferred to nylon
embranes, and hybridized to 32P-labeled probes pre-
ared by random hexamer priming as previously de-
cribed (McVoy and Adler, 1994).
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